A new report said that medical and medication discovery decreases in Europe, with patent requests submitted by 2024.
The Global number of company patent applications is stable in 2024, but technology Clinical And the lack of pharmaceutical products, according to Annual patent table The European Patent Office (OEP) released on Tuesday.
The Oep Registered 199,264 requests Patent Last year, after three years of growth. Applications from Europe have increased by 0.3%, and the ones outside Europe have declined slightly, 0.4%.
Although General Panorama may seem to be confident, there is a field that faces difficulties: Apps Field Medical technologyThey fell 3% With a total of 15,701 requests compared to the previous year. The Medical technologies They include medical equipment to detect and treat diseases, including vaccine devices, prostheses and surgical robots.
The leading country in this field AmericaWith 38.2% applications. Dutch company Royal Philips, with 594 applications, and the US Johnson & Johnson, 564. He Pharmaceutical As the demands declined by 13.2%, it also met with a decrease, which put the total patents to 8,359 in 2024.
In this field, the leading country Back America37% with applications. However, this refers to a decline of 16.9% compared to the previous year. In Europe, despite the general decline, the Netherlands submitted 6.5% more patent applications than 2023.
The Bi technologyThis includes peptides, microbiology and gene engineering, with an increase of 5.4% in the same period, reaching a total of 8,479 patents. One more time, America headed for this sector36%of all requests. In Europe, Germany is the main taxpayerWith almost 10% applications.
